PROTEOMONITOR SUBSCRIBERS: NRC Spinoff Aims to Commercialize FAIMS as Next-Generation Protein Separation Device

Dec 05, 2001

This story is available to ProteoMonitor subscribers.

Breaking News

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.